SEC Filing Summary: 180 Life Sciences Corp. (ATNF)
Business Context and Reporting Period
This Form 8-K was filed on December 12, 2024, reporting events occurring on December 10, 2024. The registrant, 180 Life Sciences Corp., is a Delaware corporation listed on The NASDAQ Capital Market under the symbols ATNF (Common Stock) and ATNFW (Warrants). The filing addresses regulatory compliance matters regarding the company's audit committee structure.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing compliance rather than financial performance.
Material Changes
The primary material change reported is the resolution of a Nasdaq listing deficiency. Previously, on May 15, 2024, the company was notified of non-compliance with Nasdaq Listing Rule 5605(c)(2) regarding the requirement for an audit committee of at least three independent directors. On December 10, 2024, following the appointment of Steven H. Shoemaker to the audit committee, Nasdaq issued written notice confirming the company's compliance with the rule, effectively closing the matter.
Guidance, Outlook, and Risks
The filing contains no specific financial guidance or operational outlook. It includes standard forward-looking statements cautioning that actual results may differ materially from projections due to risks described in the company's Annual Reports on Form 10-K and other SEC filings. The document notes that the company disclaims any obligation to update these statements except as required by law.
Key Facts for Investor Verification
- Compliance Status: Verify that the audit committee now consists of at least three independent directors as required by Nasdaq rules.
- Appointment Details: Confirm the background and independence status of Steven H. Shoemaker, the newly appointed audit committee member.
- Listing Risk: Monitor future filings to ensure no new listing deficiencies arise, as the company previously faced delisting risks related to governance.
- Management Changes: Note that Blair Jordan is serving as Interim Chief Executive Officer, as indicated in the signature block.